Literature DB >> 20868587

Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.

Pietro Leccese, Salvatore D'Angelo, Padula Angela, Gabriella Coniglio, Ignazio Olivieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20868587

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

1.  Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease.

Authors:  Suhail Aamar; Hagit Peleg; David Leibowitz; Tova Chajek-Shaul; Nurith Hiller; Samuel N Heyman
Journal:  Rheumatol Int       Date:  2013-02-15       Impact factor: 2.631

Review 2.  Behçet's Disease and Nervous System Involvement.

Authors:  Murat Kürtüncü; Erdem Tüzün; Gulsen Akman-Demir
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.598

3.  Anakinra treatment in drug-resistant Behcet's disease: a case series.

Authors:  Luca Cantarini; Antonio Vitale; Perla Scalini; Charles A Dinarello; Donato Rigante; Rossella Franceschini; Gabriele Simonini; Giulia Borsari; Francesco Caso; Orso Maria Lucherini; Bruno Frediani; Ilaria Bertoldi; Leonardo Punzi; Mauro Galeazzi; Rolando Cimaz
Journal:  Clin Rheumatol       Date:  2013-12-05       Impact factor: 2.980

4.  Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.

Authors:  Yue Li; Zelong Han; Xianfei Wang; Zhihui Mo; Wei Zhang; Aimin Li; Side Liu
Journal:  BMC Gastroenterol       Date:  2013-12-09       Impact factor: 3.067

Review 5.  Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.

Authors:  Seema Kalra; Alan Silman; Gulsen Akman-Demir; Saeed Bohlega; Afshin Borhani-Haghighi; Cris S Constantinescu; Habib Houman; Alfred Mahr; Carlos Salvarani; Petros P Sfikakis; Aksel Siva; Adnan Al-Araji
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

6.  Infliximab is a plausible alternative for neurologic complications of Behçet disease.

Authors:  Burcu Zeydan; Ugur Uygunoglu; Sabahattin Saip; Onat N Demirci; Emire Seyahi; Serdal Ugurlu; Vedat Hamuryudan; Aksel Siva; Orhun H Kantarci
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.